Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 USD | 0.00% | +25.00% | -35.00% |
04-19 | Subchapter V Trustee Appointed Under Chapter 11 for Histogen Inc. | CI |
04-18 | Histogen Inc. Filed for Bankruptcy | CI |
Sales 2021 | 1.03M 81.92M | Sales 2022 | 3.77M 299M | Capitalization | 3.55M 281M |
---|---|---|---|---|---|
Net income 2021 | -15M -1.19B | Net income 2022 | -10M -794M | EV / Sales 2021 | 2.62 x |
Net cash position 2021 | 13.92M 1.1B | Net cash position 2022 | 7.48M 594M | EV / Sales 2022 | -1.04 x |
P/E ratio 2021 |
-0.85
x | P/E ratio 2022 |
-0.24
x | Employees | 7 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.15% |
1 week | +25.00% | ||
Current month | -43.04% | ||
1 month | -60.00% | ||
3 months | -41.18% | ||
6 months | -38.48% | ||
Current year | -35.00% |
Managers | Title | Age | Since |
---|---|---|---|
Susan Knudson
CEO | Chief Executive Officer | 60 | 26/05/20 |
Mark A. Hubka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas L. Hubka
PRN | Corporate Officer/Principal | 37 | 25/05/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Kisner
CHM | Chairman | 77 | 31/01/14 |
Director/Board Member | 54 | 24/03/21 | |
David Crean
BRD | Director/Board Member | 59 | 25/05/20 |
Date | Price | Change | Volume |
---|---|---|---|
10/05/24 | 0.2 | 0.00% | 170 |
08/05/24 | 0.2 | +25.00% | 735 |
07/05/24 | 0.16 | +6.67% | 424 |
Delayed Quote OTC Markets, May 10, 2024 at 03:54 pm
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.00% | 854K | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- HSTO Stock